Lion’s Mane and Cognitive Function: What Human Evidence Shows
Human Lion’s Mane cognition research, including small randomized trials, preparation differences and limits when applying results to supplements.
Mild Cognitive Impairment Trial
A small randomized trial in adults aged 50–80 with mild cognitive impairment used Lion’s Mane material over 16 weeks and reported improved cognitive scores during treatment. The study was small, and the intervention was roughly gram-level daily material rather than a simple 500 mg comparison.
Other Human Research
A later randomized trial also examined cognitive outcomes with Lion’s Mane. Across the human literature, formulations, populations and endpoints differ, which limits simple “clinically proven” conclusions.
Relevance to NeuroVera
NeuroVera reports 500 mg of Lion’s Mane. That makes the research relevant, but it does not establish equivalence to trials using different amounts or preparations, and it does not test the full six-ingredient NeuroVera formula.
Safety Context
People with mushroom allergies should use particular caution. As with any supplement, medication use and medical conditions can change individual suitability.
Sources & References
- Mori et al. — Lion’s Mane and mild cognitive impairment (PubMed)
- Saitsu et al. — Lion’s Mane randomized trial (PubMed)
- NCCIH — Dietary Supplements and Cognitive Function
Product pages are used for seller-reported facts such as current formula, price and guarantee. They are not treated as independent proof of effectiveness.